IL13 and neoplasm: Produced by multiple components in the TME (63), IL-4 and IL-13 and their receptor systems are able to influence malignant behavior (64), via altering tumor proliferation, survival, and metastatic ability or suppressing tumor-directed immune surveillance mechanisms (64–66).